Sagimet Biosciences Inc - Class A (SGMT) Company Profile & Statistics

Sagimet Biosciences Inc - Class A
SGMT
(Nasdaq - US)
Closed
5.80
+0.38 (+7.01%)
in:usd•As of: Nov 05, 2024 15:59 UTC -5
Open
5.67
High
5.84
Low
5.39

About Sagimet Biosciences Inc - Class A

CEO

David Happel

Headquarters

155 bovet rd., suite 303

san mateo, ca 94402, united states

Auditor

Deloitte & Touche LLP

Employees

Share Holders

Website

https://sagimet.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

Sagimet Biosciences Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel therapeutics targeting dysfunctional metabolic pathways. Sagimet Biosciences Inc. is based in SAN MATEO, Calif.

Sagimet Biosciences Inc - Class A Statistics

Valuation Measures

Market Capitalization ²	166.26M
Enterprise Value	70.30M
Enterprise Value/EBITDA (ttm)	-1.90
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	0.93
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-79.41%
Return on Equity (ttm)	-20.81%
Return on Invested Capital (ttm)	-23.36%
Return on Assets (ttm)	-20.06%

Income Statement

Revenue (ttm)	2.00M
Revenue Per Share (ttm)	0.07
Gross Profit (ttm)	2.00M
EBITDA (ttm)³	-36.94M
Net Income Avi to Common (ttm)	-29.25M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	2.29
52-Week Change	54.67%
S&P500 52-Week Change	32.45%
S&P500 Member	No
Stock Optionable	Yes
Total Shares Outstanding ¹	30.67M
Dividend Yield	0.00%
Float ⁴	25.28M
% Held by Insiders	17.60%
% Held by Institutions	87.86%

Balance Sheet

Total Cash (mrq)	166.37M
Total Cash Per Share (mrq)	5.42
Total Debt (mrq)	0.00
Total Debt/Equity (mrq)	0.00%
Current Ratio (mrq)	29.11%
Quick Ratio (mrq)	29.11%
Book Value Per Share (mrq)	5.74

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.37
Free Cash Flow (ytd)	-11.84M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Sagimet Biosciences Inc - Class A

Trade With A Regulated Broker